Cargando…

New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population

BACKGROUND: To investigate whether the known diabetes mellitus (KDM) or newly diagnosed diabetes mellitus (NDM) could be regarded as a coronary heart disease (CHD) risk equivalent among a relatively young Middle East population with high prevalence of diabetes mellitus (DM). METHODS: A population ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadaegh, Farzad, Fahimfar, Nooshin, Khalili, Davood, Sheikholeslami, Farhad, Azizi, Fereidoun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016329/
https://www.ncbi.nlm.nih.gov/pubmed/21129219
http://dx.doi.org/10.1186/1475-2840-9-84
_version_ 1782195722416816128
author Hadaegh, Farzad
Fahimfar, Nooshin
Khalili, Davood
Sheikholeslami, Farhad
Azizi, Fereidoun
author_facet Hadaegh, Farzad
Fahimfar, Nooshin
Khalili, Davood
Sheikholeslami, Farhad
Azizi, Fereidoun
author_sort Hadaegh, Farzad
collection PubMed
description BACKGROUND: To investigate whether the known diabetes mellitus (KDM) or newly diagnosed diabetes mellitus (NDM) could be regarded as a coronary heart disease (CHD) risk equivalent among a relatively young Middle East population with high prevalence of diabetes mellitus (DM). METHODS: A population based cohort study of 2267 men and 2931 women, aged ≥ 30 years. Prior CHD was defined as self-reported or ECG positive CHD at baseline, KDM as subjects using any kind of glucose-lowering medications and NDM according to fasting plasma glucose and 2-h postchallenge glycemia. Participants were categorized to six groups according to the presence of known or newly diagnosed DM and CHD at baseline (DM-/CHD-, DM-/CHD+, NDM+/CHD-, NDM+/CHD+, KDM+/CHD-, KDM+/CHD+) and Cox regression analysis were used to estimate the hazard ratio (HR) of CHD events for these DM/CHD groups, given DM-/CHD-as the reference. RESULTS: During 7.6-year follow up, 358 CHD events occurred. After controlling traditional risk factors, HRs of CHD events for DM-/CHD+ group were 2.1 (95% CI: 1.4-3.1) and 5.2 (3.2-8.3) in men and women respectively. Corresponding HRs for NDM+/CHD-were 1.7 (1.1-2.7) and 3.1 (1.8-5.6) and for KDM+/CHD-were 1.7 (0.9-3.3) and 6.2 (3.6-10.6) in men and women respectively. The HRs for NDM+/CHD+ and KDM+/CHD+ groups (i.e. participants with history of both diabetes and CHD) were 6.4 (3.2-12.9) and 8.0 (4.3-14.8) in women and 3.2 (1.9-5.6) and 4.2 (2.2-7.8) in men, respectively. The hazard of CHD events did not differ between KDM+/CHD-and DM-/CHD+ in both genders using paired homogeneity test, however the HR for NDM+/CHD-was marginally lower than the HR for DM-/CHD+ in women (p = 0.085). CONCLUSIONS: KDM patients in both genders and NDM especially in men exhibited a CHD risk comparable to nondiabetics with a prior CHD, furthermore diabetic subjects with prior CHD had the worst prognosis, by far more harmful in women than men; reinforcing the urgent need for intensive care and prophylactic treatment for cardiovascular diseases.
format Text
id pubmed-3016329
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30163292011-01-06 New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population Hadaegh, Farzad Fahimfar, Nooshin Khalili, Davood Sheikholeslami, Farhad Azizi, Fereidoun Cardiovasc Diabetol Original Investigation BACKGROUND: To investigate whether the known diabetes mellitus (KDM) or newly diagnosed diabetes mellitus (NDM) could be regarded as a coronary heart disease (CHD) risk equivalent among a relatively young Middle East population with high prevalence of diabetes mellitus (DM). METHODS: A population based cohort study of 2267 men and 2931 women, aged ≥ 30 years. Prior CHD was defined as self-reported or ECG positive CHD at baseline, KDM as subjects using any kind of glucose-lowering medications and NDM according to fasting plasma glucose and 2-h postchallenge glycemia. Participants were categorized to six groups according to the presence of known or newly diagnosed DM and CHD at baseline (DM-/CHD-, DM-/CHD+, NDM+/CHD-, NDM+/CHD+, KDM+/CHD-, KDM+/CHD+) and Cox regression analysis were used to estimate the hazard ratio (HR) of CHD events for these DM/CHD groups, given DM-/CHD-as the reference. RESULTS: During 7.6-year follow up, 358 CHD events occurred. After controlling traditional risk factors, HRs of CHD events for DM-/CHD+ group were 2.1 (95% CI: 1.4-3.1) and 5.2 (3.2-8.3) in men and women respectively. Corresponding HRs for NDM+/CHD-were 1.7 (1.1-2.7) and 3.1 (1.8-5.6) and for KDM+/CHD-were 1.7 (0.9-3.3) and 6.2 (3.6-10.6) in men and women respectively. The HRs for NDM+/CHD+ and KDM+/CHD+ groups (i.e. participants with history of both diabetes and CHD) were 6.4 (3.2-12.9) and 8.0 (4.3-14.8) in women and 3.2 (1.9-5.6) and 4.2 (2.2-7.8) in men, respectively. The hazard of CHD events did not differ between KDM+/CHD-and DM-/CHD+ in both genders using paired homogeneity test, however the HR for NDM+/CHD-was marginally lower than the HR for DM-/CHD+ in women (p = 0.085). CONCLUSIONS: KDM patients in both genders and NDM especially in men exhibited a CHD risk comparable to nondiabetics with a prior CHD, furthermore diabetic subjects with prior CHD had the worst prognosis, by far more harmful in women than men; reinforcing the urgent need for intensive care and prophylactic treatment for cardiovascular diseases. BioMed Central 2010-12-04 /pmc/articles/PMC3016329/ /pubmed/21129219 http://dx.doi.org/10.1186/1475-2840-9-84 Text en Copyright ©2010 Hadaegh et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Hadaegh, Farzad
Fahimfar, Nooshin
Khalili, Davood
Sheikholeslami, Farhad
Azizi, Fereidoun
New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
title New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
title_full New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
title_fullStr New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
title_full_unstemmed New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
title_short New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
title_sort new and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016329/
https://www.ncbi.nlm.nih.gov/pubmed/21129219
http://dx.doi.org/10.1186/1475-2840-9-84
work_keys_str_mv AT hadaeghfarzad newandknowntype2diabetesascoronaryheartdiseaseequivalentresultsfrom76yearfollowupinamiddleeastpopulation
AT fahimfarnooshin newandknowntype2diabetesascoronaryheartdiseaseequivalentresultsfrom76yearfollowupinamiddleeastpopulation
AT khalilidavood newandknowntype2diabetesascoronaryheartdiseaseequivalentresultsfrom76yearfollowupinamiddleeastpopulation
AT sheikholeslamifarhad newandknowntype2diabetesascoronaryheartdiseaseequivalentresultsfrom76yearfollowupinamiddleeastpopulation
AT azizifereidoun newandknowntype2diabetesascoronaryheartdiseaseequivalentresultsfrom76yearfollowupinamiddleeastpopulation